These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 8757608

  • 1. Different CD40-mediated signaling events require distinct CD40 structural features.
    Hostager BS, Hsing Y, Harms DE, Bishop GA.
    J Immunol; 1996 Aug 01; 157(3):1047-53. PubMed ID: 8757608
    [Abstract] [Full Text] [Related]

  • 2. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
    Hsing Y, Hostager BS, Bishop GA.
    J Immunol; 1997 Nov 15; 159(10):4898-906. PubMed ID: 9366415
    [Abstract] [Full Text] [Related]

  • 3. Identification of distinct domains in CD40 involved in B7-1 induction or growth inhibition.
    Goldstein MD, Watts TH.
    J Immunol; 1996 Oct 01; 157(7):2837-43. PubMed ID: 8816387
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of LFA-1 (CD11a/CD18) cytoplasmic domains in binding to intercellular adhesion molecule-1 (CD54) and in postreceptor cell spreading.
    Pyszniak AM, Carpenito C, Takei F.
    Exp Cell Res; 1997 May 25; 233(1):78-87. PubMed ID: 9184078
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40.
    Starling GC, Kiener PA, Aruffo A, Bajorath J.
    Biochemistry; 1998 Mar 17; 37(11):3723-6. PubMed ID: 9521690
    [Abstract] [Full Text] [Related]

  • 10. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS, Miller HG, Everdeen DS, Dang TT, Crute JJ, Kehry MR.
    Biochemistry; 1998 Aug 25; 37(34):11836-45. PubMed ID: 9718306
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential requirements for LFA-1 binding to ICAM-1 and LFA-1-mediated cell aggregation.
    Petruzzelli L, Maduzia L, Springer TA.
    J Immunol; 1998 May 01; 160(9):4208-16. PubMed ID: 9574521
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Specific blockade by CD54 and MHC II of CD40-mediated signaling for B cell proliferation and survival.
    Doyle IS, Hollmann CA, Crispe IN, Owens T.
    Exp Cell Res; 2001 May 01; 265(2):312-8. PubMed ID: 11302697
    [Abstract] [Full Text] [Related]

  • 18. Constitutive expression of functional CD40 on mouse renal cancer cells: induction of Fas and Fas-mediated killing by CD40L.
    Lee JK, Seki N, Sayers TJ, Subleski J, Gruys EM, Murphy WJ, Wiltrout RH.
    Cell Immunol; 2005 Jun 01; 235(2):145-52. PubMed ID: 16213477
    [Abstract] [Full Text] [Related]

  • 19. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1.
    Usui Y, Okunuki Y, Hattori T, Takeuchi M, Kezuka T, Goto H, Usui M.
    Invest Ophthalmol Vis Sci; 2006 Oct 01; 47(10):4607-13. PubMed ID: 17003458
    [Abstract] [Full Text] [Related]

  • 20. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
    Izzi L, Turbide C, Houde C, Kunath T, Beauchemin N.
    Oncogene; 1999 Sep 30; 18(40):5563-72. PubMed ID: 10523833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.